Company
Crescent Biopharma, Inc.
Crescent Biopharma, Inc. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| CR-001 | Phase 1/2 | Locally Advanced / Metastatic Solid Tumors |
Latest
No recent events.
Follow Crescent Biopharma, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.